Compare
Gilead Sciences vs Harmony Biosciences Holdings (GILD vs HRMY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Gilead Sciences (GILD) returned +36.1% and Harmony Biosciences Holdings (HRMY) +5.6%; so far this year the figures are +36.0% and -11.5%.
Gilead Sciences is the larger company by market value, about 106.7 times the size of Harmony Biosciences Holdings.
Revenue grew +6.5% at GILD and +19.8% at HRMY over the last year.
GILD yields 1.95%. HRMY pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| GILD | HRMY | |
|---|---|---|
| Price | $166.89 | $33.11 |
| 1-day | -0.41% | +1.97% |
| YTD | +35.97% | -11.52% |
| 1 year | +36.15% | +5.61% |
| 3 years | +108.12% | +35.03% |
| Market cap | $207.0B | $1.9B |
| P/E | — | 10.9 |
| P/S | 6.68 | 1.97 |
| P/B | 15.87 | 1.81 |
| Revenue growth | +6.50% | +19.80% |
| EPS growth | -149.00% | -4.70% |
| Gross margin % | 79.9 | 74.0 |
| Net margin % | -12.5 | 18.1 |
| ROE % | -29.6 | 16.7 |
| Debt / equity | 2.01 | 0.14 |
| FCF yield % | 6.7 | 16.6 |
| Dividend yield % | 1.95 | — |
| Beta | 0.37 | 0.59 |
| RSI (14) | 60.2 | 30.9 |
| Technical rating |